Brief: Bonesupport: CERAMENT G Categorized As Breakthrough Device For Indication Trauma By FDA
17/06/2021 09:03
June 17 (Reuters) - Bonesupport Holding AB BONEX.ST :
* CERAMENT G HAS BEEN CATEGORIZED AS A BREAKTHROUGH DEVICE
FOR
INDICATION TRAUMA BY US FOOD AND DRUG ADMINISTRATION (FDA).
* A POTENTIAL APPROVAL FOR INDICATION TRAUMA MAY BECOME
EFFECTIVE
AT END OF 2022
Source text for Eikon: ID:nWkr88YlfB
Further company coverage: BONEX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))